Both Tirzepatide Injection and Semaglutide Injection represent significant advancements in diabetes management, particularly for individuals with type 2 blood sugar. While both are injectable medications that mimic natural hormones to lower blood sugar, they function through unique mechanisms. Semaglutide primarily acts as a GLP-1 receptor agonist,